The role of corticotropin-releasing factor in depression and anxiety disorders

Journal of Endocrinology

Volumn 160, Issue 1, 1999, Pages 1-12

  Arborelius, L ^a   Owens, M J ^a   Plotsky, P M ^a   Nemeroff, C B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST;

AFFECTIVE NEUROSIS; ANXIETY NEUROSIS; CEREBROSPINAL FLUID LEVEL; CHILD ABUSE; DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIBIDO; LIFE EVENT; LOCUS CERULEUS; NEGLECT; NONHUMAN; NORADRENERGIC SYSTEM; PREVALENCE; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; STRESS;

ADULT; ANIMALS; ANXIETY DISORDERS; CHILD, PRESCHOOL; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; DISEASE MODELS, ANIMAL; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; MATERNAL DEPRIVATION; NEURONS; PITUITARY-ADRENAL SYSTEM; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS, PSYCHOLOGICAL;

EID: 0032899957     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1600001     Document Type: Review

References (112)

1. Adinoff B, Anton R, Linnoila M, Guidotti A, Nemeroff CB & Bissette G 1996 Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. Neuropsychopharmacology 15 288-295.
2. Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL & Gold PW 1992 Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Archives of General Psychiatry 49 9-20.
3. Altemus M, Swedo SE, Leonard HL, Richter D, Rubinow DR, Potter WZ & Rapoport JL 1994 Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Archives of General Psychiatry 51 794-803.
4. Amsterdam JD, Maislin G, Winokur A, Berwish N, Kling M & Gold P 1988 The oCRH test before and after clinical recovery from depression. Journal of Affective Disorders 14 213-222.
5. Antoni FA 1986 Hypothalamic control of ACTH secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocrine Reviews 7 351-370.
6. Arató M, Bánki CM, Nemeroff CB & Bissette G 1986 Hypothalamic-pituitary-adrenal axis and suicide. Annals of the New York Academy of Sciences 487 263-270.
7. Arató M, Bánki CM, Bissette G & Nemeroff CB 1989 Elevated CSF CRF in suicide victims. Biological Psychiatry 24 355-359.
8. Axelson DA, Doraiswamy PM, Boyko OB, Escalona PR, McDonald WM, Ritchie JC, Patterson LJ, Ellinwood EH, Nemeroff CB & Krishnan KRR 1992 In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Research 46 63-70.
9. Bánki CM, Bissette G, Arató M, O'Connor I. & Nemeroff CB 1987 Cerebrospinal fluid corticotropin-releasing factor-like immuno-reactivity in depression and schizophrenia. American Journal of Psychiatry 144 873-877.
10. Bánki CM, Karmacsi L, Bissette G & Nemeroff CB 1992a Cerebrospinal fluid neuropeptides in mood disorders and dementia. Journal of Affective Disorders 25 39-46.
11. Bánki CM, Karmacsi L, Bissette G & Nemeroff CB 1992b CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. European Neuropsychopharmacology 2 107-113.
12. Barbazanges A, Piazza PV, Le Moal M & Maccari S 1996 Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. Journal of Neuroscience 16 3943-3949.
13. Board F, Persky H & Hamburg DA 1956 Psychological stress and endocrine functions. Psychosomatic Medicine 18 324-333.
14. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB & Charney DS 1997 Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. American Journal of Psychiatry 154 624-629.
15. Brown GW, Bifulco A & Harris TO 1987 Life events, vulnerability and onset of depression. British Journal of Psychiatry 150 30-42.
16. Butler PD, Weiss JM, Stout JC & Nemeroff CB 1990 Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. Journal of Neuroscience 10 176-183.
17. Catalani A, Marinelli M, Scaccianoce S, Nicolai R, Muscolo LAA, Porcu A, Korányi L, Piazza PV & Angelucci L. 1993 Progeny of mothers drinking corticosterone during lactation have lower stress-induced corticosterone secretion and better cognitive performance. Brain Research 624 209-215
18. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP & De Souza EB 1996 Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends in Pharmacological Sciences 17 166-172.
19. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C & Nemeroff CB 1986 Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. Journal of Neuroscience 6 2908-2914.
20. Chappell P, Leckman J, Goodman W, Bissette G, Pauls D, Anderson G, Riddle M, Scahill L, McDougle C & Cohen D 1996 Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls. Biological Psychiatry 39 776-783.
21. Charney DS, Bremner JD & Redmond DF 1995 Noradrenergic neural substrates for anxiety and fear: clinical associations based on preclinical research. In Psychopharmacology: The Fourth Generation of Progress. pp 387-395. Eds FE Bloom & DJ Kupfer. New York: Raven Press.
22. Coplan JD, Andrews MW, Rosenblum LA, Owens MJ, Friedman S, Gorman JM & Nemeroff CB 1996 Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proceedings of the National Academy of Sciences of the USA 93 1619-1623.
23. De Bellis MD, Gold PW, Geracioti TD, Listwak S & Kling MA 1993 Fluoxetine significantly reduces CSF CRH and AVP concentrations in patients with major depression. American Journal of Psychiatry 150 656-657.
24. De Kloet ER 1991 Brain corticosteroid receptor balance and homeostatic control. Frontiers in Neuroendocrinology 12 95-164.
25. De Souza EB & Grigoriadis DE 1995 Corticotropin-releasing factor: physiology, pharmacology, and role in central neurvous system and immune disorders. In Psychopharmacology: The Fourth Generation of Progress, pp 505-517. Eds FE Bloom & DJ Kupfer, New York: Raven Press.
26. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM & Vale WW 1996a Cloning and characterization of human urocortin. Endocrinology 137 2167-2170.
27. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM & Vale WW 1996b Erratum. Endocrinology 137 3896.
28. Dunn AJ & Berridge CW 1990 Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress response? Brain Research Reviews 15 71-100.
29. Dunner D, Patrick V & Fieve RR 1979 Life events at the onset of bipolar affective illness. American Journal of Psychiatry 136 508-511.
30. Fossey MD, Lydiard RB, Ballenger JC, Laraia MT, Bissette G & Nemeroff CB 1996 Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects. Biological Psychiatry 39 703-707.
31. France RD, Urban B, Krishnan KRR, Bissette G, Bánki CM, Nemeroff CB & Speilman FJ 1988 CSF corticotropin-releasing factor-like immunoreactivity in chronic pain patients with and without major depression. Biological Psychiatry 23 86-88.
32. Geracioti TD, Loosen PT & Orth DN 1997 Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biological Psychiatry 42 166-174.
33. Gertz BJ, Cantreras LN, McComb DJ, Kovacs K, Tyrrell JB & Dallman MF 1987 Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number. Endocrinology 120 381-388.
34. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Avgerinos P, Paul S, Oldfield EH, Cutler GB & Chrousos GP 1986 Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: pathophysiologic and diagnostic implications. New England Journal of Medicine 314 1329-1335.
35. Gray TS & Bingaman EW 1996 The amygdala: corticotropin-releasing factor, steroids, and stress. Critical Reviews in Neurobiology 10 155-168.
36. 2α) receptors. Molecular Pharmacology 50 679-686.
37. Hammen C, Davila J, Brown C, Ellicott A & Gitlin M 1992 Psychiatric history and stress: predictors of severity of unipolar depression. Journal of Abnormal Psychiatry 101 45-52.
38. Hawley RJ, Nemeroff CB, Bissette G, Guidotti A, Rawlings R & Linnoila M 1994 Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. Alcoholism: Clinical and Experimental Research 18 1312-1316.
39. Heim C, Owens MJ, Plotsky P & Nemeroff CB 1997 The role of early adverse life events in the etiology of depression and post-traumatic stress disorder: focus on corticotropin-releasing factor. Annals of the New York Academy of Sciences 821 194-207.
40. Heinrichs SC, Menzaghi F, Merlo Pich E, Britton KT & Koob GF 1995 The role of CRF in behavioral aspects of stress. Annals of the New York: Academy of Sciences 771 92-104.
41. 2, receptors mediate anxiogenic-like behavior. Regulatory Peptides 71 15-21.
42. Henry C, Kabbaj M, Simon H, Le Moal M & Maccari S 1994 Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. Journal of Neuroendocrinology 6 341-345.
43. Holsboer F & Barden N 1996 Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews 17 187-205.
44. Holsboer F, Gerken A, von Bardeleben U, Grimm W, Beyer H, Muller OA & Stella GK 1986 Human corticotropin-releasing hormone in depression. Biological Psychiatry 21 601-611.
45. Holsboer F, Lauer CJ, Schreiber W & Krieg J-C 1995 Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorder. Neuroendocrinology 62 340-347.
46. Iino K, Sasano H, Oki Y, Andoh N, Shin R-W, Kitamoto T, Totsune K, Takahashi K, Suzuki H, Nagura H & Yoshimi T 1997 Urocortin expression in human pituitary gland and pituitary adenoma. Journal of Clinical Endocrinology and Metabolism 82 3842-3850.
47. Jacobson L & Sapolsky RM 1991 The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenal axis. Endocrine Reviews 12 118-134.
48. Joëls M & De Kloet E 1994 Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Progress in Neurobiology 43 1-36.
49. Jolkkonen J, Lepola U, Bissette G, Nemeroff CB & Riekkinen 1993 CSF corticotropin-releasing factor is not affected in panic disorder. Biological Psychiatry 33 136-138.
50. Kalin NH 1990 Behavioral and endocrine studies of corticotropin-releasing hormone in primates. In Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptides, pp 275-289. Eds EB De Souza & CB Nemeroff. Boca Raton. FL: CRC Press, Inc.
51. Kendler KS, Neale MC, Kessler RC, Heath AC & Eaves LJ 1992 Childhood parental loss and adult psychopathology in women. Archives of General Psychiatry 49 109-116.
52. Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP & Gold PW 1991 Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. Journal of Clinical Endocrinology and Metabolism 72 260-271.
53. Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP & Gold PW 1993 Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Neuroendocrinology 57 79-88.
54. Kling MA, De Bellis MD, O'Rourke DK, Listwak SJ, Geracioti TD, McCutcheon IE, Kalogeras KT, Oldfield EH & Gold PW 1994a Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers. Journal of Clinical Endocrinology and Metabolism 79 233-239.
55. Kling MA, Geracioti TD, Licinio J, Michelson D, Oldfield EH & Gold PW 1994b Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: preliminary findings. Psychopharmacology Bulletin 30 489-494.
56. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K & Britton KT 1993 The role of corticotropin-releasing factor in behavioral responses to stress. In Cortocotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide, pp 277-295. Eds EB De Souza & CB Nemeroff. CIBA Foundation Symposium 172. Chichester: John Wiley & Sons.
57. Krishnan KRR, Doraiswamy PM, Lurie SN, Figiel GS, Husain MM, Boyko OB, Ellinwood EH Jr & Nemeroff CB 1991 Pituitary size in depression. Journal of Clinical Endocrinology and Metabolism 72 256-259.
58. Krishnan KRR, Rayasam K, Reed DR, Smith M, Chappell P, Saunders WB, Ritchie JC, Carroll BJ & Nemeroff CB 1993 The corticotropin-releasing factor stimulation test in patients with major depression: relationship to dexamethasone suppression test results. Depression 1 133-136.
59. Ladd CO, Owens MJ & Nemeroff CB 1996 Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology 137 1212-1218.
60. Lee S & Rivier C 1992 Administration of corticosterone to pregnant adrenalectomized dams does not alter the hypothalamic-pituitary-adrenal axis' activity of the offspring. Molecular and Cellular Neuroscience 3 118-123.
61. Lee SY, Imaki T, Vale W & Rivier CR 1990 Effects of prenatal exposure to ethanol on the activity of hypothalamic-pituitary-adrenal axis in offspring: importance of the time of exposure to ethanol and possible modulating mechanisms. Molecular and Cellular Neuroscience 1 168-177.
62. Levine S 1994 The ontogeny of the hypothalamic-pituitary-adrenal axis. The influence of maternal factors. Annals of the New York Academy of Sciences 746 275-288.
63. Levine S, Lyons DM & Schatzberg AF 1947 Psychobiological consequences of social relationships. Annals of the New York Academy of Sciences 807 210-218.
64. Liu D, Caldji C, Sharma S, Plotsky PM & Meaney MJ 1998 Influence of neonatal rearing condition on stress-induced hypothalamic-pituitary-adrenal responses and norepinephrine release in the hypothalamic paraventricular nucleus. Journal of Neuroscience. (In Press).
65. McCauley J, Kem DE, Kolodner K, Dill L, Schroeder AF, DeChant HK, Ryden J, Derogatis LR & Bass EB 1997 Clinical characteristics of women with a history at childhood abuse: unhealed wounds. Journal of the American Medical Association 277 1362-1368.
66. McKinney WT, Moran & Kraemer GW 1984 Separation in non-human primates as a model for human depression: neurobiological implications. In Neurobiology of Mood Disorder, pp 393-406. Eds R Post & J Ballenger. Baltimore: Williams and Wilkins.
67. Maes M & Meltzer HY 1995 The serotonin hypothesis of major depression. In Psychopharmacology: The Fourth Generation of Progress. pp 933-944. Eds FE Bloom & DJ Kupfer. New York: Raven Press.
68. Melia KR & Duman RS 1991 Involvement of corticotropin-releasing factor in chronic stress regulation of brain noradrenergic system. Proceedings of the National Academy of Sciences of the USA 88 8382-8386.
69. Menzaghi F, Heinrichs SC, Pich EM, Weiss F & Koob GF 1993 The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress. Annals of the New York Academy of Sciences 697 142-154.
70. Molchan SE, Hill JL, Martinez RA, Lawlor BA, Mellow AM, Rubinow DR, Bissette G, Nemeroff CB & Sunderland T 1993 CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinolgy 19 509-519.
71. Nemeroff CB, Widerlöv E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT & Vale W 1984 Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226 1342-1344.
72. Nemeroff CB, Owens MJ, Bissette G, Andorn AC & Stanley M 1988 Reduced corticotropin-releasing factor binding sites in the frontal cortex of suicide victims. Archives of General Psychiatry 45 577-579.
73. Nemeroff CB, Bissette G, Akil H & Fink M 1991 Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy: corticotropin-releasing factor, β-endorphin and somatostatin. British Journal of Psychiatry 158 59-63.
74. Nemeroff CB, Krishnan KRR, Reed D, Leder D, Beam C & Dunnick NR 1992 Adrenal gland enlargement in major depression: a computed tomography study. Archives of General Psychiatry 49 196-202.
75. Nemeroff CB, Owens MJ, Plott SJ & Levnie S 1993 Increased density of regional brain CRF binding sites after maternal deprivation. Society for Neuroscience Abstract 19 1.
76. Owens MJ & Nemeroff CB 1991 Physiology and pharmacology of corticotropin-releasing factor. Pharmacological Reviews 43 425-473.
77. Owens MJ & Nemeroff CB 1994 Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clinical Chemistry 40 288-295.
78. Owens MJ, Bissette G & Nemeroff CB 1989 Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 4 196-202.
79. Owens MJ, Vargas MA, Knight DL & Nemeroff CB 1991 The effects ot alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal. Journal of Pharmacology and Experimental Therapeutics 258 349-356.
80. Pihoker C, Owens MJ, Kuhn CM, Schanberg SM & Nemeroff CB 1993 Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: a putative role for corticotropin-releasing factor. Psychoneuroendocrinology 18 485-493.
81. Pitts AF, Samuelson SD, Meller WH, Bissette G, Nemeroff CB & Kathol RG 1995 Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls. Biological Psychiatry 38 330-335.
82. Plotsky PM 1991 Pathways to the secretion of adrenocorticotropin: a view from the portal. Journal of Neuroendocrinology 3 1-9.
83. Plotsky P & Meaney M 1993 Early postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA. median eminence CRF content, and stress-induced release in adult rats. Molecular Brain Research 18 195-200.
84. Plotsky P, Owens MJ & Nemeroff CB 1995a Neuropeptide alterations in affective disorders. In Psychopharmacology: The Fourth Genaration of Progress, pp 971-981. Eds FE Bloom & DJ Kupfer. New York: Raven Press.
85. Plotsky P, Su Y, Keng C & Thrivikraman KV 1995b Neonatal separation alters HPA axis function, central CRF mRNA levels, behavior, and alcohol preference in adult rats. Society for Neuroscience Abstracts 21 500.
86. Plotsky PM, Thrivikraman KV, Su Y, Caldji C, Sharma & Meaney MJ 1998 The effects on neonatal rearing environment on CRF mRNA and CRF receptor levels in adult rat brain. Journal of Neuroscience. (In Press).
87. Post RM, Gold P, Rubinow DR, Ballenger JC, Bunney WE & Goodwin FK 1982 Peptides in cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function. Life Sciences 31 1-15.
88. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ & Swaab DF 1994 Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Clinical Neuroendocrinology 60 436-444.
89. Raadsheer FC, Van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ. Tilders FJ & Swaab DF 1995 Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. American Journal of Psychiatry 152 1372-1376.
90. Risch SC, Lewine RJ, Jewart RD, Pollard WE, Caudle JM, Kalin NH. Stipetic M, Eccard MB & Risby ED 1991 Relationship between cerebrospinal fluid peptides and neurotransmitters in depression. In Central Nervous System Peptide Mechanism in Stress and Depression, pp 93-103. Ed SC Risch. Washington DC.: American Psychiatric Press.
91. Rosenblum LA & Paully GS 1984 The effects of varying environmental demands on maternal and infant behavior. Child Development 55 305-314.
92. Roy A, Pickar D, Paul S, Doran A, Chrousos GP & Gold PW 1987 CSF corticotropin-releasing hormone in depressed patients and normal subjects. American Journal of Psychiatry 144 641-645.
93. Roy-Byrne PP, Uhde T, Post R, Galucci W, Chrousos GP & Gold PW 1986 The conicotropin-releasing hormone stimulation test in patients with panic disorder. American Journal of Psychiatry 143 896-899.
94. Rubin RT, Phillips JJ, Sadow TF & McCracken JT 1995 Adrenal gland volume in major depression: increase during the depressive episode and decrease with successful treatment. Archives in General Psychiatry 52 213-218.
95. Sapolsky RM & Plotsky PM 1990 Hypercortisolism and its possible neural basis. Biological Psychiatry 27 937-952.
96. Shapiro 1968 Maturation of the neuroendocrine response to stress in the rat. In Early Experience and Behavior, pp 198-257. Eds G Newton & S Levine. Springfield, IL: Charles C Thomas.
97. Skutella T, Criswell H, Moy S, Probst JC, Breese GR, Jirikowski GF & Holsboer F 1994 Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxioty affects in rat. Neuroreport 2 2181-2185.
98. Smagin GN, Swiergiel AH & Dunn AJ 1995 Conicotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Research Bulliten 36 71-77.
99. Smith GW, Aubry J-M, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W & Lee K-F 1998 Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20 1093-1102.
100. Smith MA, Davidson J, Ritchie JC. Kudler H, Lipper S, Chappel P & Nemeroff CB 1989 The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biological Psychiatry 26 349-355.
101. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF & Vale WW 1994 Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. Journal of Neuroscience 14 2579-2584.
102. Suomi SJ 1991 Early stress and adult emotional reactivity in rhesus monkeys. Ciba Foundation Symposium 156 171-188.
103. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JMHM, Stalla GK, Blanquet V, Steckler T, Holsboer F & Wurst W 1998 Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genetics 19 162-166.
104. Vale WJ, Spiess J, Rivier C & Rivier J 1981 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213 1394-1396.
105. Valentino RJ, Foote SL & Aston-Jones G 1983 Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Research 270 363-367.
106. Van Bockstaele EJ, Colago EEO & Valentino RJ 1996 Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. Journal of Comparative Neurology 364 523-534.
107. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE & Valle W 1995 Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378 287-292.
108. Walker CD, Perrin M, Vale W & Rivier C 1986 Ontogeny of the stress response in the rat: role of the pituitary and the hypothalamus. Endocrinology 118 1445-1451.
109. Weiss JM, Stout J, Aaron M, Owens MJ & Nemeroff CB 1994 Experimental studies of depression and anxiety: role of lucos coeruleus and corticotropin-releasing factor. Brain Research Bulliten 35 561-572.
110. Widerlöv E, Bissette G & Nemeroff CB 1988 Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients. Journal of Affective Disorders 14 99-107.
111. Wong M-L, Al-Shekkhlee A, Bongiorno PB, Esposito A, Khatri P, Sternberg EM, Gold PW & Licinio J 1996 Localization of urocortin messenger RNA in rat brain and pituitary. Molecular Psychiatry 1 307-312.
112. Yehuda R 1997 Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder. Annals of the New York Academy of Sciences 821 57-75.